Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Return on Invested Capital (2021 - 2025)

Biofrontera has reported Return on Invested Capital over the past 5 years, most recently at 0.03% for Q4 2025.

  • For Q4 2025, Return on Invested Capital rose 1.0% year-over-year to 0.03%; the TTM value through Dec 2025 reached 0.03%, up 1.0%, while the annual FY2025 figure was 0.02%, 1.0% up from the prior year.
  • Return on Invested Capital for Q4 2025 was 0.03% at Biofrontera, down from 0.05% in the prior quarter.
  • Over five years, Return on Invested Capital peaked at 0.18% in Q4 2021 and troughed at 0.21% in Q2 2021.
  • A 5-year average of 0.02% and a median of 0.02% in 2022 define the central range for Return on Invested Capital.
  • On a YoY basis, Return on Invested Capital climbed as much as 20bps in 2022 and fell as far as -19bps in 2022.
  • Year by year, Return on Invested Capital stood at 0.18% in 2021, then plummeted by -104bps to 0.01% in 2022, then plummeted by -289bps to 0.03% in 2023, then fell by -29bps to 0.03% in 2024, then increased by 17bps to 0.03% in 2025.
  • Business Quant data shows Return on Invested Capital for BFRI at 0.03% in Q4 2025, 0.05% in Q3 2025, and 0.08% in Q2 2025.